The Emotional Meeting of an Eye Tissue Donor’s Family and Researchers

Tim Anegon’s wife and daughter recently connected with the U-M scientists working with his eye tissue donation — and saw the gift’s outsize impact.

7:00 AM

Author | Shantell M. Kirkendoll

When Tim Anegon became an eye tissue donor after his death in 2014, it wasn't just one person he would touch with his eyes — it was millions.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

His family recently got to see that impact in action when they visited the lab of Patrice E. Fort, Ph.D., the University of Michigan researcher whose team is putting Anegon's cells to good use. They got there with the help of the nonprofit group Eversight Michigan, which focuses on restoring sight and preventing blindness. Eversight is also connecting families of eye tissue donors with researchers working to cure eye diseases.

The family visited with Fort at the U-M Kellogg Eye Center. There, they saw how Anegon's tissue and cells are an invaluable tool in the fight against diabetic eye disease.

"In research, we start with animal models and cell models, but those have limitations," says Fort, a research assistant professor in ophthalmology and visual sciences. "If we want to understand how diabetes affects the human retina, we will find the most meaningful answers with human tissue from eye donation."

Today, more than 32 million people worldwide are blind and 200 million others have moderate to severe visual impairment, according to Eversight.

Eye donation has fueled major advances in understanding blinding diseases such as glaucoma and age-related macular degeneration. But researchers face a shortage of human eye tissue as the number of eyes donated for research continues to decline, according to a recent paper in JAMA Ophthalmology.

Donating hope

Through organ and tissue donation, families donate for a chance at cures or a new life for recipients. In Tim Anegon's case, he was on both sides of the process.

When Anegon, of Saginaw, Michigan, received a liver transplant, his family understood it was only possible because a donor gave the gift of life. Anegon died of complications after the transplant, and his family decided to be an organ donor family.

SEE ALSO: One Patient Sees a Corneal Transplant's Transformative Effect

"He was 50 when he got sick. He had just turned 54 when he passed," says his wife, Coleen Anegon. "He lived a lot of life in those 54 years. He lived well and loved his children."

Meeting with researchers helped his family continue his story.

"Donating his cornea and eye tissue seemed so insignificant compared to an organ," says daughter Courtney Anegon. "But we realized from the researchers today that improving someone's quality of life is huge, in ways that we can't even begin to understand."

From donation to vision research

Fort says many people diagnosed with diabetes will experience retinal issues during the course of their disease, which causes varying degrees of vision loss.

"They start losing vision at some point, to some degree," he says. "For some of them it's going to be complete blindness, for others it's going to be a little bit more subtle, but all of them virtually will have problems with their vision."

At Kellogg, a repository of eye tissue that includes Anegon's is being developed to investigate aspects of diabetic retinopathy, including damage to blood vessels in the eye, inflammation and retinal cell death. The collection will include nondiabetic and diabetic tissue and is expected to be used for years to come.

SEE ALSO: Making Prosthetic Eyes That Look Like the Real Thing

Meanwhile, Eversight is working to increase the number of people who join the donor registry and consent to research to increase accessibility to eye tissue. The organization arranged the meeting between the Anegon family and Fort as part of its Hope and Healing program, which celebrates the gift of donated eye tissue to research.

"The Hope and Healing program gives families a chance to see the real impact of research donation," says Colleen Vrba, Eversight research programs manager. "Knowing that your loved one's donation is helping to find therapies and treatments for blinding eye diseases has a tremendous meaning for families."
 

Visit Donate Life to learn more about organ, eye and tissue donation and to register as an organ, eye and tissue donor. Registration is fast and secure.


More Articles About: Eye Health Eye Care & Vision Transplant Kellogg Eye Center Hospitals & Centers
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Vision Impairment as a Risk Factor for Dementia
The population of older adults living with dementia is expected to swell to nearly 14 million by 2050 and is estimated to cost the US economy more than 500 billion each year. In the absence of a cure for Alzheimer's disease, the primary cause of dementia, there's interest in understanding modifiable risk factors. In theory, getting a handle on the modifiable risk factors for dementia, would enable public health efforts to reduce cognitive decline in dementia at the population level. We've come a long way in understanding the risk factors for Alzheimer's disease and other related dementias. However, there's still work to be done. In this episode, we'll speak with Dr. Josh Ehrlich, a researcher at the University of Michigan, who has examined vision impairment as a risk factor for dementia.
wheelchair walker image
Health Lab
Spread of drug resistant bacteria linked to patient hand contamination and antibiotic use within nursing homes
A Michigan Medicine research team seeks to identify characteristics of patients within nursing homes, as well as the nursing home environment itself, that are associated with contamination by vancomycin-resistant enterococci.
graphic drawing of colonoscopy scan with large intestine vials patient on bed doctor
Health Lab
Investment in free follow up colonoscopies will pay off
Free colonoscopies for people whose at-home stool tests (such as Cologuard and FIT) turn up signs of potential cancer are now covered by insurance, and a study shows this will save money.
surgeons in OR with blue and teal scrubs with screen on and patient under teal sheet
Health Lab
Treating heart valve disease: What are your options?
Michigan Medicine’s head of cardiac surgery, Gorav Ailawadi, M.D, M.B.A., answers questions about different treatment options for heart valve disease.
Health Lab
How bedside musicians helped one family cope with tragedy
How the gifts of art and beside music and art programs helped one family cope with tragedy
pill bottle spilling yellow blue
Health Lab
Oral steroid usage increased across U.S., Taiwan and Denmark in past decade
Research from the University of Michigan finds that over the past decade, there has been a steady increase of oral steroids prescriptions not only in the United States, but in Taiwan and Denmark as well.